Most likely, the implicated tumor-promoting effects of CXCR3 can be explained by the tumor cell autonomous expression of this chemokine receptor and its described positive impact on cancer cell motility, resulting in an increased metastasis-forming capacity [36,37]. The gene discussed is CXCR3; the disease is cancer.